Menu

Extinct and Living Elephants’ Genomic History Sequenced

Gene flow between elephant species was a common feature of their evolutionary history.

Feb 27, 2018
Jim Daley

Swazi (center), a female African savanna elephant from which a reference genome was sequenced, at the San Diego ZooSAN DIEGO ZOO GLOBAL

By sequencing the genomes of 14 living and extinct species of elephantids, a consortium of researchers has found that throughout their evolutionary histories, different elephant species frequently interbred. As they describe in PNAS yesterday (February 26), the scientists sequenced the genomes of an extinct woolly mammoth, a Columbian mammoth, a straight-tusked elephant, and an American mastodon, as well as living African forest elephants, African savanna elephants, and Asian elephants.

The research “will be a reference point for understanding how diverse elephants are related to each other and it will be a model for conducting similar studies in other species groups,” says study coauthor Kerstin Lindblad-Toh, a genomicist at the Broad Institute, in a statement.

The researchers reconstructed the evolutionary history of elephants by generating genomes for living elephants and comparing them to a high-quality genome from a straight-tusked elephant that died 120,000 years ago. They also generated genome-wide data from several ancient mammoths and mastodons. The straight-tusked elephant descended from lineages that are related to the woolly mammoth, ancient African elephants, and present-day forest elephants.

The analysis further revealed that different elephant species regularly hybridized during their evolution. It also found that the African forest and savanna elephants appear to have diverged more than 2 million years ago, and have been genetically isolated for about 500,000 years. The finding settles the debate over whether African forest and savannah elephants are different species, with each warranting its own conservation efforts.

“Observationally, people knew that Savanna and Forest elephants did not have much interbreeding,” Rebekah Rogers, an evolutionary geneticist at the University of California, Berkeley, who wasn’t involved in the new study, tells Gizmodo. “This paper tells us that the elephants weren’t sneaking around behind our backs or passing around genes at lower rates. The genetics suggest that the rates of successful interbreeding [were] very low.”

Study coauthor David Reich, a geneticist at the Harvard Medical School, says the data show “that these two species have been isolated for long periods of time, making each worthy of independent conservation status.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.